Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Nir Uriel
Outcomes of Transcatheter Aortic Valve Replacement for Aortic Regurgitation in LVAD Patients: The JENA-VAD Study
JACC Journals › JACC › Archives › Just Accepted Research Article : JACC Just Accepted Formats available You can view the full content in the following formats: Metrics & Citations How to cite this article: Ramana, R, Uriel, N, Yadav, P. et al. Outcomes of Transcatheter Aortic Valve Replacement for Aortic Regurgitation in LVAD Patients: The JENA-VAD Study. JACC. 2026, 0 (0) .
Heart Replacement Therapy in Young Patients: A Comparative Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry
JACC Journals › JACC: Heart Failure › Archives › Vol.
Survival Outcomes in Middle-Aged and Older Patients With Advanced Heart Failure: A Propensity-Matched Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry
JACC Journals › JACC: Heart Failure › Archives › Vol.
Physician-Directed Patient Self-Management Using an Implantable IVC Congestion Sensor: Insights From FUTURE-HFII
Heart failure (HF) remains a leading cause of hospitalization worldwide, with congestion accounting for most admissions and readmissions.1,2 Despite advances in pharmacologic and device therapy, recurrent decompensation continues to drive morbidity, mortality, and escalating health care utilization.3,4 Efforts to promote patient self-management in HF have historically relied on symptoms, body weight, and intermittent vital signs.
Multimodal multi-instance learning for cardiopulmonary exercise testing performance prediction
|
Abstract Heart failure (HF) is a progressive and fatal disease that affects nearly 7 million individuals in the United States, with prevalence expected to surpass 10 million by 2040. Cardiopulmonary exercise testing (CPET) represents the gold standard for assessing functional capacity and predicting survival outcomes among HF patients but its widespread use is limited by practical constraints.
By Zhe Huang, Weishen Pan, Shudhanshu Alishetti, Ashley Beecy, Zhenzhen Liu, Albert Gong, Saebyeol Shin, Kevin J. Clerkin, Rochelle L. Goldsmith, David T. Majure, Chris Kelsey, David vanMaanan, Jeffrey A. Ruhl, Naomi Tesfuzigta, Erica Lancet, Deepa Kumaraiah, Gabriel Sayer, Deborah Estrin, Kilian Q. Weinberger, Nir Uriel, Fei Wang
|
Nature
Verified
Novel artificial intelligence applications in heart transplantation
Get full text access Log in, subscribe or purchase for full access. References 1. Biondi-Zoccai, G. ∙ Mahajan, A. ∙ Powell, D. ... Advancing cardiovascular care through actionable AI innovation Npj Digit Med. 2025; 8:1-5 2. Elias, P. ∙ Jain, S.S. ∙ Poterucha, T. ... Artificial Intelligence for Cardiovascular Care—Part 1: Advances: JACC Review Topic of the Week J Am Coll Cardiol. 2024; 83:2472-2486 3. Jain, S.S. ∙ Elias, P. ∙ Poterucha, T. ...
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM
Video Published: Views: 17 Likes: 0 Average (ratings) HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.
Innovative CCM-D Device Outcomes in Heart Failure Study
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial. Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation capabilities for patients with heart failure with reduced ejection fraction.
Omitting Aspirin in High-Risk Left Ventricular Assist Device Implant
Omitting Aspirin in High-Risk Left Ventricular Assist Device Implant Aspirin After LVAD Implantation and Arterial Vascular Disease Finn Gustafsson, MD, PhD; Nir Uriel, MD, MSc; Ivan Netuka, MD, PhD; Jason N. Katz, MD, MHS; Francis D. Pagani, MD, PhD; Jean M. Connors, MD; Ulrich P. Jorde, MD; Daniel Zimpfer, MD, PhD; Yuriy Pya, MD, DMSc; Jennifer Conway, MD, MSc; Anelechi Anyanwu, MD; Anna Mara Scandroglio, MD; Nasir Sulemanjee, MD; Pavan Atluri, MD; Mary Keebler, MD; Craig H. Selzman, MD; Jeffrey D.
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device:
1. "Global challenges in left ventricular assist device therapy: a tale across two continents". Eur J Heart Fail . 2022;24:1316-1318. 2. "A fully magnetically levitated left ventricular assist device". N Engl J Med . 2019;380:1618-1627. 3. "Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants". Eur J Heart Fail . 2021;23:1392-1400. 4.
Incidence and Clinical Correlates of De‐novo Aortic Regurgitation with a Fully Magnetically Levitated LVAD: A MOMENTUM3 Trial Portfolio Analysis
Abstract Aims We assessed the incidence, predictors and clinical correlates of Aortic Regurgitation (AR), which physiologically reduces left ventricular assist device (LVAD) effectiveness due to recirculation syndrome, in the MOMENTUM 3 trial portfolio of the fully magnetically levitated HM3 pump using the pivotal randomized trial (PT) and post-approval continued access protocol (CAP).
Primary Results of Long‐Term Outcomes in the MOMENTUM 3 Pivotal Trial and Continued Access Protocol Study Phase: A Study of 2200 HeartMate 3 Left Ventricular Assist Device Implants
Research Article Mandeep R. Mehra MD, MSc Corresponding Author mmehra@bwh.harvard.edu Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA Corresponding author. Mandeep R.
Should It Be Called
Shunichi Nakagawa, MD Shunichi Nakagawa Affiliations Department of Medicine, Adult Palliative Care Services, Columbia University Irving Medical Center, New York, New York, USA Search for articles by this author Nir Uriel, MD, MSc Nir Uriel Affiliations Department of Medicine, NYP Heart Failure, Heart Transplant & Mechanical Circulatory Support Programs, Columbia University Irving Medical Center, New York, New York, USA Search for articles by this author Kenneth M. Prager, MD Kenneth M.
Myocardial Injury in COVID-19 Patients
Journal of the American College of Cardiology Editorial Comment Nir Uriel, Gabriel Sayer and Kevin J. Clerkin This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article. Author + information This article requires a subscription or purchase to view the full text.
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019
Key Points Question What are the characteristics and outcomes of patients with heart transplant who are infected with coronavirus disease 2019 (COVID-19)? Findings In this case series of 28 patients who had received heart transplant in a large academic center, the case fatality rate among patients infected with COVID-19 was 25%. Cardiovascular comorbidities were frequent in this population, and immunosuppressive therapy was reduced in most patients.
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
From September 2014 through November 2015, a total of 366 patients underwent randomization (190 patients to the centrifugal-flow pump group and 176 patients to the axial-flow pump group). The baseline characteristics of the patients in the two treatment groups are presented in Table 1, and in Tables S1 and S2 in the Supplementary Appendix.
Reverse remodelling and myocardial recovery in heart failure
1.Hochman, J. S. & Bulkley, B. H. Expansion of acute myocardial infarction: an experimental study. Circulation 65, 1446–1450 (1982).2.Erlebacher, J. A. et al. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am. J. Cardiol. 49, 1120–1126 (1982).3.Pfeffer, J. M., Pfeffer, M. A., Fletcher, P. J. & Braunwald, E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 260, H1406–H1414 (1991).4.Burkhoff, D. et al.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nir
Contact Nir, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack